Peter M. Strothman

Partner at Water Street Healthcare Partners LLC

Peter M. Strothman

Peter M. Strothman

Partner at Water Street Healthcare Partners LLC

Overview
RelSci Relationships

1400

Number of Boards

6

Birthday

1977

Age

43

Contact Data
Trying to get in touch with Peter M. Strothman? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Peter M. Strothman likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founding Member at Water Street Healthcare Partners LLC

Relationship likelihood: Strong

Operating Partner at Water Street Healthcare Partners LLC

Relationship likelihood: Strong

Partner at Ampersand Management LLC

Relationship likelihood: Strong

Partner at JLL Partners, Inc.

Relationship likelihood: Strong

Founding Member at Water Street Healthcare Partners LLC

Relationship likelihood: Strong

Founder at Water Street Healthcare Partners LLC

Relationship likelihood: Strong

Executive Chairman at CATO Research Ltd.

Relationship likelihood: Strong

Chief Executive Officer, Life Sciences Services Platform at JLL Partners, Inc.

Relationship likelihood: Strong

Partner & Managing Director-Principal Investors & Private Equity at The Boston Consulting Group, Inc.

Relationship likelihood: Strong

Operating Partner at Ampersand Management LLC

Relationship likelihood: Strong

Paths to Peter M. Strothman
Potential Connections via
Relationship Science
You
Peter M. Strothman
Partner at Water Street Healthcare Partners LLC
Career History
Partner
Current

Water Street Healthcare Partners focuses exclusively on investments in the healthcare sector. The firm invests in middle-market companies and lower-priority divisions of global companies in the following areas: diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals and specialty services. Water Street does not invest in biotechnology, traditional healthcare facilities such as hospitals or nursing homes or in early-stage companies without positive cash flow. They firm looks for companies with: (1) a leading market share (2) established brands and/or strong customer relationships (3) strong sales and distribution capabilities (4) platforms with the potential for expansion into new products, services and technologies and (5) management teams interested in retaining an ownership stake. Investments typically range from $50 million to $500 million.

Principal
2006 - 2009

JLL Partners focuses on healthcare, financial services, industrial, building products, education, aerospace and defense and business services sectors.JLL Partners is a control investor and sources its deals from its deep network of industry contacts, applying its proven, value-oriented investment approach to provide limited partners with attractive risk-adjusted returns throughout all investment cycles. They seek to add value and insight by sharing their financial and operational expertise with fundamentally strong companies experiencing regulatory, legal, operational or financial difficulties that prevent them from taking advantage of favorable, long-term, secular growth trends in their industry.The firm closely and actively partners with proven management teams to build market-leading companies. They go beyond financial support, and provide their portfolio companies with the operating experience, in developing new products and executing bolt-on acquisitions.

Vice President
2002 - 2005

Cypress Group invests in privately negotiated transactions, targeting operating businesses and investing with management to foster continued growth.The firm focuses on the following industries: aerospace/defense, automotive, building products, construction materials, consumer products, financial services, general industrial, healthcare, lodging and leisure, media/entertainment, packaging, retail and services.

Boards & Committees
Director
2009 - Prior

inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ.

Transactions
Details Hidden

Water Street Healthcare Partners LLC, MedPlast Tempe Inc. /Private Group, JLL Partners, Inc. purchase Viant Medical LLC from Harvey Equity Partners LLC, JZ International Ltd., Baird Capital Partners, Fidus Investment Advisors LLC, Parkway Capital Investors LLC, River Cities Capital Funds

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Peter M. Strothman. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Peter M. Strothman's profile does not indicate a business or promotional relationship of any kind between RelSci and Peter M. Strothman.